Novocure’s device shown to slow cancer progression in the brain in trial
Novocure’s therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of lung cancer, the company said.
Novocure’s therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of lung cancer, the company said.
The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge’s heart devices in patients as they faced…
Targets to improve England’s rivers, lakes and coastal water will fall well short, a key watchdog finds.
This is the last year that students in England will get formulae sheets in maths and science.
Teva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie’s blockbuster arthritis drug Humira in the coming weeks after it…
The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge’s heart devices in patients as they faced…
Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic,…
Upper Tract Urothelial Cancer (UTUC), Circulating tumor DNA (ctDNA), Circulating Tumour DNA in Plasma Is Feasible and May Be a Potential Biomarker, detection of tumor-specific…
Teva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie’s blockbuster arthritis drug Humira in the coming weeks after it…
Abstract. Among adults at risk for severe coronavirus disease 2019 (COVID-19), the lowest hospitalization rate was among those who received nirmatrelvir-ri
PADUA Renal (SPARE) Nephrometry Scoring System, Renal Function Outcomes After Robot-Assisted Partial Nephrectomy, Robot-Assisted Partial Nephrectomy, UroCCR Study 93, Chronic Kidney Disease (CKD), RAPN for…